Asia-Pacific enteral feeding formula market is projected to register a CAGR of 7.8% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027
Market Segmentation:
Asia-Pacific Enteral Feeding Formula Market, By Product (Standard Formulas and Disease-Specific Formulas), Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology and Others) Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrostomy Tube Feeding and Duodenal or Jejunal Tube Feeding), Stage (Adult and Pediatric), End User (Hospitals and Long Term Care Facilities), Country (Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of Asia-Pacific) Industry Trends & Forecast to 2020

Some of the major factors contributing to the growth of the Asia-Pacific enteral feeding formula market are:
• Increase in the incidence of chronic diseases
• Increasing healthcare expenditure
Market Players:

The key market players for Asia-Pacific enteral feeding formula market are listed below:

• Nutricia Advanced Medical Nutrition
• Hormel Foods Corporation
• Medline Industries, Inc
• Mead Johnson & Company, LLC.
• Nestlé Health Science
• Abbott
• Meiji Holdings Co., Ltd.
• Fresenius Kabi Ltd (A subsidiary of Fresenius SE & Co. KGaA)
• B. Braun Melsungen AG